Dow Down1.29% Nasdaq Down3.25%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM
12.13 Up 2.00(19.74%) Feb 5, 4:00PM EST
|After Hours : 12.14 Up 0.01 (0.08%) Feb 5, 7:28PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 38,586   35,052   28,133   30,801  
Cost of Revenue2,248  1,762  1,618  2,282  
Gross Profit 36,338   33,290   26,515   28,519  
Operating Expenses
Research Development9,129  6,878  3,683  5,770  
Selling General and Administrative22,900  23,335  19,402  18,019  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 4,309   3,077   3,430   4,730  
Income from Continuing Operations
Total Other Income/Expenses Net263  (78)(2,070)814  
Earnings Before Interest And Taxes4,572  2,999  1,360  8,136  
Interest Expense292  331  381  1,189  
Income Before Tax4,280  2,668  979  6,947  
Income Tax Expense58  662  62   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops4,197  1,765  (1,217)6,947  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 4,222   2,006   917   4,355  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 4,222   2,006   917   4,355  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.